FORM C |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB APPROVAL |
| OMB Number: ####-#### Estimated average burden hours per response: ##.# |
Form C: Filer Information
Filer CIK: | 0001651239 |
Filer CCC: | XXXXXXXX |
Period: | 12-31-2022 |
Is this a LIVE or TEST Filing? | LIVE TEST |
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption? | |
Would you like a Return Copy? |
Submission Contact Information
Name: | |
Phone Number: | |
Contact E-Mail Address: | |
Notify via Filing Website only? |
Form C: Issuer Information
Issuer Information
Name of Issuer: | Quadrant Biosciences Inc |
Legal Status of Issuer:
Form: | Corporation |
Jurisdiction of Incorporation/Organization: |
DELAWARE
|
Date of Incorporation/Organization: | 03-13-2015 |
Physical Address of Issuer:
Address 1: | 505 IRVING AVENUE |
Address 2: | SUITE 3100 A-B |
City: | SYRACUSE |
State/Country: |
NEW YORK
|
Mailing Zip/Postal Code: | 13210 |
Website of Issuer: | quadrantbiosciences.com |
Form C: Annual Report Disclosure Requirements
Annual Report Disclosure Requirements
Current Number of Employees: | 126.00 |
Total Assets Most Recent Fiscal Year-end: | 36301229.00 |
Total Assets Prior Fiscal Year-end: | 38227705.00 |
Cash and Cash Equivalents Most Recent Fiscal Year-end: | 13882387.00 |
Cash and Cash Equivalents Prior Fiscal Year-end: | 8116233.00 |
Accounts Receivable Most Recent Fiscal Year-end: | 1411933.00 |
Accounts Receivable Prior Fiscal Year-end: | 13651979.00 |
Short-term Debt Most Recent Fiscal Year-end: | 8833130.00 |
Short-term Debt Prior Fiscal Year-end: | 7393024.00 |
Long-term Debt Most Recent Fiscal Year-end: | 1900436.00 |
Long-term Debt Prior Fiscal Year-end: | 7016522.00 |
Revenue/Sales Most Recent Fiscal Year-end: | 36395155.00 |
Revenue/Sales Prior Fiscal Year-end: | 60519179.00 |
Cost of Goods Sold Most Recent Fiscal Year-end: | 14340093.00 |
Cost of Goods Sold Prior Fiscal Year-end: | 33466238.00 |
Taxes Paid Most Recent Fiscal Year-end: | 57859.00 |
Taxes Paid Prior Fiscal Year-end: | 159290.00 |
Net Income Most Recent Fiscal Year-end: | -2444757.00 |
Net Income Prior Fiscal Year-end: | 12247807.00 |
Form C: Signature
Signature
Issuer: | Quadrant Biosciences Inc |
Signature: | Richard Uhlig |
Title: | Chief Executive Officer, Chairman |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Richard Uhlig |
Title: | Chief Executive Officer, Chairman |
Date: | 04-28-2023 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Richard Bongo |
Title: | Chief Financial Officer, Principal Accounting Officer, Director |
Date: | 04-28-2023 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | James Croke |
Title: | Director |
Date: | 04-28-2023 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Peter Cohen |
Title: | Director |
Date: | 04-28-2023 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Ira Fedder |
Title: | Director |
Date: | 04-28-2023 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Andrew Rock |
Title: | Director |
Date: | 04-28-2023 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Mary Ann Tyszko |
Title: | Director |
Date: | 04-28-2023 |